{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3343, 
        3349
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4074, 
        4080
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4534, 
        4540
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3350, 
        3359
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3963, 
        3972
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4081, 
        4090
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4504, 
        4513
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6737, 
        6757
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6759, 
        6767
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3837, 
        3864
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3866, 
        3876
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3879, 
        3883
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4018, 
        4022
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4311, 
        4315
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6667, 
        6668
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6702, 
        6703
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6719, 
        6720
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3891, 
        3910
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        3928, 
        3938
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4270, 
        4289
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6662, 
        6664
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        546, 
        575
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        577, 
        594
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3025, 
        3060
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3062, 
        3074
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6606, 
        6632
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6634, 
        6652
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3939, 
        3972
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3952, 
        3962
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4065, 
        4073
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4487, 
        4495
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Ben,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4738, 
        4739
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3884, 
        3890
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4023, 
        4029
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4496, 
        4503
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6669, 
        6675
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6704, 
        6710
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6721, 
        6727
      ]
    }
  ], 
  "Positive Findings Phraseology (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3310, 
        3342
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4330, 
        4350
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3876, 
        3878
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6654, 
        6661
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6676, 
        6683
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6711, 
        6718
      ]
    }
  ], 
  "__text": "MSH|^~\\&|LABCORP-CORP|LABCORP^34D0655059^CLIA|Cancer Registry|State|201706010938|State006|ORU^R01|2017060107093839521000|P|2.3.1\nPID|1||^^^^SS^~11111111^^^^PI^|ALTERNATE ID|TEST^PATIENT^A||19500601|M||2054-5^Black or African American^CDC^^^|1234 Test Road^^ALBANY^NY^12201||^^^^^222^1234567|||||||\nORC|RE||111A1111111||||||||||||||||||Ordering Facility Name^^L|2222 W. Test Road^^Test^TX^77025|^^^^^111^1234567||\nOBR|1||111A1111111|^^^111111^Pathology Report^L|||201705301335|||||||20090115||Ordering Provider Name||||||20170530|||F|||||||\n\n\n\n\n\n\nPath report.gross observation\n\nGross description: The specimens are received in formalin, labeled with the patient's name and sublabeled as the following: (1) SN #1 left; (2) new medial margin left breast; (3) left breast. \n (1) The specimen was previously received unfixed for frozen section  performed at Edmonds Center for Outpatient Surgery and consists of a  piece of fatty tissue (2.0 x 1.5 x 0.7 cm) containing a lymph node.  Section code: (A1) remaining tissue from frozen section; (A2)  remaining fatty tissue. Specimen entirely submitted. (2) The specimen consists of a piece of breast tissue (1.8 x 0.5 x 1.3 cm)  with no overlying skin. The specimen is partially inked (purple-  anterior; yellow-posterior; green-medial. No localization wire is  present. The specimen is serially sectioned AP into seven slices with  the anterior and posterior resection margins as slices as #1 and #7,  respectively. The breast tissue is fatty and contains a firm irregular  pale area (0.3 x 0.2 x 0.1 cm) located in slice #3. Slices #3-#5 are  focally hemorrhagic. No scirrhous areas are identified. Section code:  (B1) anterior resection margin, perpendicularly sectioned; (B2) slice  #2; (B3) slice #3; (B4) slice #4; (B5) slice #5; (B6) slice #6; (B7)  posterior resection margin, perpendicularly sectioned. Specimen  entirely submitted. (3) The specimen was previously received unfixed for intraoperative consultation  performed at Edmonds Center for Outpatient Surgery and consists of an  inked and sliced piece of breast tissue (1.0 cm AP, 2.7 cm ML, 3.1 cm  SI) with a localization wire exiting the medial aspect. The specimen  is received serially sectioned LM into five slices with the lateral  and medial resection margins as slices #1 and #5, respectively. The  breast tissue is fatty and contains a mass at the medial margin. No  other nodules, masses or lesions are identified. Ink code:  purple-anterior; yellow-posterior; black-superior; orange-inferior;  green-medial; blue-lateral. Section code: (C1) slice #5 perpendicularly sectioned; (C2) lateral resection margin, perpendicularly sectioned; (C3) slice #2; (C4) slice #3; (C5) slice #4. Specimen entirely submitted. \n Note: Approximate total fixation time in formalin for all specimens-31 hours 20 minutes, calculated using a collection date of 07/25/2017 with no collection time given. (JM:cmc10 717444) /MRV\n\n\nPayment procedure\n\nCPT                            .883071, 883072, 883073, 883311, 883291, W20061\n\n\nPath report.microscopic observation\n\nMicroscopic: An immunohistochemical stain was performed on block C1 to evaluate the cells of interest. Control stain showed appropriate reactivity. \n Result: E-Cadherin: Positive in the cells of interest. \n Interpretation: E-Cadherin positivity is consistent with the diagnosis of ductal carcinoma. \n \n * This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research.\n\n\nPATHOLOGIST NAME\n\nElectronically signed: Pathologist name, Pathologist\n\n\nDiagnosis ICD code\n\nPathologist provided ICD-10:C50.512\n\n\nPath report.final diagnosis\n\nDiagnosis:A. Left Breast Sentinel Lymph Node, Excision:   One lymph node negative for metastatic carcinoma.   Please see CAP summary data below. \n B-C. Left Breast, Excision And New Medial Margin:   Invasive ductal carcinoma.   Please see CAP summary cancer data below. \n \n CAP CANCER CASE SUMMARY Invasive carcinoma of the breast: Procedure: Excision with image-guided localization Lymph node sampling: Sentinel lymph node Specimen Laterality: Left \n Tumor site: Lower outer quadrant. Tumor size: 9 mm x 7 mm, and two separate foci of microinvasion       associated with DCIS measuring 1 mm and 0.5 mm. Histologic type: Invasive mammary carcinoma of no special type (ductal,         not otherwise specified). Histologic grade: Nottingham Histologic Score Glandular/Tubular Differentiation: Score 3 Nuclear Pleomorphism: Score 2 Mitotic Rate: Score 1 Overall Grade: Grade 2 Tumor focality: Multiple foci of invasive carcinoma         Sizes of individual foci: 9 mm, 1 mm, 0.5 mm. Ductal carcinoma in situ: DCIS is present.             Positive for extensive intraductal component. Size (Extent) of DCIS: 1.5 cm in maximum dimension. Architectural patterns: Cribriform and solid. Nuclear grade: Grade 2 (intermediate). Necrosis: Not identified. Lobular carcinoma in situ: Not identified. \n Macroscopic and microscopic extent of tumor Skin: Not applicable. Nipple: Not applicable. Skeletal muscle: Not applicable. \n Margins Invasive carcinoma: Margins uninvolved by invasive carcinoma.  Anterior: See comment.  Posterior: Greater than 10 mm.  Superior: See comment.  Inferior: Greater than 10 mm.  Medial:  0.5 mm, See comment.  Lateral:  Greater than 10 mm. Ductal carcinoma in situ: Margins positive for DCIS.  The new medial margin is positive for DCIS with an extent of up to  12 mm on a single histologic section. See comment. \n Lymph nodes Total number of lymph nodes examined: 1 Number of sentinel lymph nodes examined: 1 Lymph Node Involvement: 0  Number of lymph nodes with macrometastases: 0  Number of lymph nodes with micrometastases: 0  Number of lymph nodes with isolated tumor cells: 0 Method of Evaluation of Sentinel Lymph Nodes: H&E, multiple levels \n Lymph-vascular invasion: Not identified. \n Pathologic staging: AJCC, 7th ed., 2010 TNM Descriptors: m (multiple foci of invasive carcinoma) Primary tumor: pT1b Regional lymph nodes: pN0(sn) \n Ancillary studies (per report): Biomarkers Performed Previously on Case: Cellnetix S17-65658. Estrogen Receptor (ER) Status: 100%, strong. Progesterone Receptor (PgR) Status: 50%, moderate. HER2 (by immunohistochemistry): Negative (score 0). Ki-67: 8%. \n Microcalcifications: not identified. BFI/07/28/2017 **********************************************************************\n\n\nPath report.site of origin\n\nMaterial submitted: PART A: SN#1 L BREAST PART B: NEW MEDIAL MARGIN L BREAST PART C: L BREAST TISSUE\n\n\nPath report.comments\n\nComment:B-C. The final size is based on 3 contiguous slices from the medial resection margin, each 3mm in thickness, and correlation with radiologic findings. The initial excision shows carcinoma and focal DCIS extending to medial margins in block C1. A small band of carcinoma less than 0.5mm extent touches an edge with overlapping black and green ink (superior medial) and the mass also extends to within 0.5 mm of anterior margin in the same section. It is likely this entire area was re-excised in the new medial margin as a small focus of carcinoma is present 2 mm from the anterior inked portion of the new medial margin (block B1). However, surgical correlation is required. \n The new medial margin has a large area of DCIS with two small separate foci of microinvasive carcinoma. DCIS extends to the new medial (green inked margin) and the closest focus of microinvasion is 0.5 mm from the new medial margin. \n \n \n \n \n \n \n \n \n \n \n \n .\n\n\n"
}